Hosted on MSN17d
The European Medicines Agency EMA has not 'admitted' that mRNA vaccines are 'experimental'
the number applications for clinical trials and marketing authorisations for mRNA containing products significantly increased ...
The Pharma Letter3d
EMA annual report 2024
At its March meeting, the European Medicines Agency’s management board adopted the EMA’s annual report for 2024. This ...
Novartis announces CHMP of EMA adopted positive opinion for Fabhalta
Novartis (NVS) announced that the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, has adopted a ...
Regeneron announces EMA CHMP adopted positive opinion on linvoseltamab
Pharmaceuticals announced that the European Medicines Agency’s, EMA, Committee for Medicinal Products for Human Use, CHMP, has ...
Precision Medicine Online4d
European Regulators Warn About Dangers of Unregulated Cell Therapies
The agency advises patients to confirm that any cell, gene, or tissue therapy they receive is approved by a regulator or authorized for use in a clinical trial.
GEN26d
C3i Center Receives EMA Approval to Manufacture Cell Therapy Products for Europe
Obtaining approvals from Health Canada and the EMA reaffirms our dedication to patient safety and the quality of therapeutic products. This level of certification makes C3i Center a Canadian ...
Health And Pharma17d
Enhertu Gains EMA’s CHMP Support for HER2-Low Metastatic Breast Cancer Treatment
The European Medicines Agency (EMA) committee (CHMP) has recommended approving trastuzumab deruxtecan (Enhertu), a HER2-directed antibody-drug conjugate for certain patients with metastatic breast ...
Financial Post26d
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
Obtaining approvals from Health Canada and the EMA reaffirms our dedication to patient safety and the quality of therapeutic products. This level of certification makes C3i Center a Canadian reference ...